Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in Singapore, TZ Healthcare Management Limited focuses on integrating investments in the healthcare sector, particularly for an ageing population. The firm addresses critical needs through disruptive medical technology, including digital diagnostics and therapeutics. TZ Healthcare manages the TZPBC Healthy Ageing Impact Venture Fund, targeting various investment stages.
Investing in pre-seed to Series C stages, TZ Healthcare specializes in disruptive medical technologies aimed at improving health outcomes for the ageing population. Their strategy includes customized structuring and commercialization of technologies, with validation in hospital and nursing home environments.
Notable technologies in TZ Healthcare's portfolio include Brain Computer Interface (BCI), which targets ADHD, Parkinson’s disease, and dementia using AI-driven analysis of brain signals. Another key investment is Photo-Neuro Intervention (PNI), a patented therapy system for neurodegenerative diseases. They also support Next-Generation PET Scans for mobile, high-definition imaging and Point-of-Care 3D Ultrasound for portable diagnostic imaging.
Submit your pitch through their form at https://tz-healthcare.com.
TZ Healthcare invests across multiple stages, including pre-seed, Seed, Seed+, Series A, Series B, and Series C.
The firm focuses on healthcare, digital health, and biotech, specifically targeting disruptive medical technologies.
Investments are validated in hospital and nursing home environments to ensure effectiveness and applicability in real-world settings.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.